| JEXFLUVY GlaxoSmithKline Biologicals SA
98383250 30 Jan 2024 | on 22 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations for the prevent... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations for the prevention of infectious diseases; Pharmaceutical preparations for the treatment of damaged skin and tissue, pain, inflammation, obesity, and infectious diseases; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, hematological, bacterial, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders | | | AUXIPDI GlaxoSmithKline Biologicals SA
98271184 15 Nov 2023 | on 15 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | AMPVYON GlaxoSmithKline Biologicals SA
98268773 14 Nov 2023 | on 15 Oct 2024
| Vaccines Class 005 Class 005 Pharmaceutical Products Vaccines | | | IPDURXO GlaxoSmithKline Biologicals SA
98268778 14 Nov 2023 | on 15 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | AUXVALI GlaxoSmithKline Biologicals SA
98271187 15 Nov 2023 | on 15 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders; | | | IPDOMVYX GlaxoSmithKline Biologicals SA
98268779 14 Nov 2023 | on 15 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | XIPDEQLI GlaxoSmithKline Biologicals SA
98268774 14 Nov 2023 | on 15 Oct 2024
| Vaccines; Anti-infectives; Pharmaceutical preparations and substances ... Class 005 Class 005 Pharmaceutical Products Vaccines; Anti-infectives; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations for the treatment of infectious diseases, pain, inflammation, obesity and cognitive disorders; Pharmaceutical preparations for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, oncological, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric and immune system related diseases and disorders | | | NEUVIPDA GlaxoSmithKline Biologicals SA
98268772 14 Nov 2023 | on 15 Oct 2024
| Vaccines Class 005 Class 005 Pharmaceutical Products Vaccines | | | VIPDURZA GlaxoSmithKline Biologicals SA
98268771 14 Nov 2023 | on 08 Oct 2024
| Vaccines Class 005 Class 005 Pharmaceutical Products Vaccines | | | VYXIPDY GlaxoSmithKline Biologicals SA
98268775 14 Nov 2023 | on 08 Oct 2024
| Vaccines Class 005 Class 005 Pharmaceutical Products Vaccines | | 
